Tag: Export of Medicines

NatiVita aims to reach the Syrian and Iraqi markets

Belarus' pharmaceutical company NatiVita (Vitebsk Oblast) intends to branch out into the Syrian and Iraqi markets in 2019-2020.

Manturov: By launching innovative drugs, we will ensure a fold increase in exports

The export of Russian pharmaceutical products in the coming years will increase several-fold and in five years will reach $ 3-4 billion a year through the launch of innovative drugs,

Borisov Pharmaceutical Plant exports more than 50% of its products

The Borisov Pharmaceutical Plant (Belarus) produces 280 different medicines, out of them 84 are available on the Russian market, according to Vitaliy Deresh, General Director of the enterprise.

Belarusian drugs are preparing to enter the US market

belarus pills
Belarusian medications are entering new markets. They will be marketed in the US. As for the European Union, one Belarusian plant has already received permission.

The finished medicinal product market of South Korea shows significant growth

South Korea's pharmaceutical market is experiencing significant growth in finished drug products, according to CPhI Korea.

Belarus will help to organize pharma manufacturing in Tajikistan

By the end of this year, Belarus and Tajikistan may elaborate a roadmap to establish joint ventures in the pharmaceutical industry, announced Oleg Ivanov, the Ambassador of Belarus in Tajikistan and Afghanistan.

Biokhimik enters Southeast Asia market

Biokhimik, a Saransk-based plant producing more than 100 medicines, wants to start supplying its products to Vietnam in late 2018 - early 2019 after obtaining the registration certificates.

Russia is ready to supply insulin to Bulgaria

Parallel export of drugs which, for some medicines, reached more than 20%, has created serious problems for diabetics. Russia is ready to fill the shortage and start exporting insulin to Bulgaria.

Russia has one of shortest periods for introducing foreign drugs onto the market

The recognition of foreign drug certificates in Russia should be based on the principles of reciprocity. This was announced by Elena Maksimkina, the Head of the Department of Drug Supply and Regulation of Medical Devices.

Belarusian pharmaceutical products will strengthen their positions in Tajikistan

belarus pills
Belarus plans to double the sales of its medicines in the market of Tajikistan. This was announced by the Minister of Health of Belarus Valery Malashko.

Sergey Tsyb: It’s important to support drug developers at the initial stage

The Russian government is actively discussing its Pharma 2030 program, which is primarily focused on the tools to support the development of new Russian-made medicines.

GENERIUM may start exporting Diaskintest to Iran in the near future

In the near future, GENERIUM plans to start exporting Diaskintest to the Islamic Republic of Iran for its use as one of the main methods for diagnosis of latent and active forms of tuberculosis.

American medicines that have analogs may be banned for importation to Russia

Leaders of parliamentary factions and Chairman of the State Duma Vyacheslav Volodin introduced a bill in response to anti-Russian policies of the United States.

Biocad signs export contracts worth about $850 million

In 2018, Biocad, a pharmaceutical company, expects that its exports outside CIS will reach 1 billion rubles, said Alexey Torgov, Deputy General Director, on April 11 at a pharmaceutical forum held in St. Petersburg.

Supplies of pharmaceuticals from Egypt to Russia jumped by 48%

In 2017, Egyptian exports to Russia grew by 35%. This was announced by Tarek Kabil, the Minister of Industry and Trade of Egypt, on April 7 in Cairo.

Kazakhstan begins exports of its pharmaceutical products to Mongolia and Vietnam

The Minister of Investment and Development of Kazakhstan Zhenis Kassymbek reported to Prime Minister Bakytzhan Sagintayev on the growth of Kazakhstan's exports.